New Announcement of Joint Research Agreement with KYORIN Pharmaceutical Co., Ltd. Announced.

Veneno Technologies, a Novel Bio-Active DRP Discovery Company, has entered into a joint research agreement with KYORIN Pharmaceutical Co., Ltd.

For more information, please click here.